LobbyingUpstream USA lobbying by quarter
Upstream USA's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q1 2023; the issues it reports most are Health Issues and Medicare/Medicaid.
Upstream USA
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q1 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2023 | $20K | 1 |
| Q2 2023 | $10K | 1 |
| Q3 2023 | $10K | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $7,005 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $23.9K | 1 |
| Q3 2025 | $15.3K | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$51.6K · 11 reports
- Medicare and Medicaid$34.6K · 6 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES12 reports
- SENATE11 reports
- Health Resources & Services Administration (HRSA)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseUpstream USA | $86.2K | 14 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/13for Q2 | In-house | Under $5,000 |
| 04/20for Q1 | In-house | Under $5,000 |
| 01/29for Q4 2025 | In-house | Under $5,000 |
| 25/10/10for Q3 2025 | In-house | $15.3K |
| 25/07/14for Q2 2025 | In-house | $23.9K |
| 25/04/15for Q1 2025 | In-house | Under $5,000 |
| 25/01/17for Q4 2024 | In-house | Under $5,000 |
| 24/10/11for Q3 2024 | In-house | Under $5,000 |
| 24/07/10for Q2 2024 | In-house | Under $5,000 |
| 24/04/12for Q1 2024 | In-house | $7,005 |
| 24/01/12for Q4 2023 | In-house | Under $5,000 |
| 23/10/13for Q3 2023 | In-house | $10K |
| 23/07/17for Q2 2023 | In-house | $10K |
| 23/04/20for Q1 2023 | In-house | $20K |
| 23/04/17for Q1 2023 | In-house | Under $5,000 |